A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Compass Pathways PLC stock. As of the latest transaction made, Renaissance Technologies LLC holds 81,400 shares of CMPS stock, worth $695,155. This represents 0.0% of its overall portfolio holdings.

Number of Shares
81,400
Previous 263,800 69.14%
Holding current value
$695,155
Previous $2.25 Million 69.14%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
N/A
-182,400 Reduced 69.14%
81,400 $695,000
Q2 2024

Aug 09, 2024

BUY
N/A
247,500 Added 1518.4%
263,800 $2.25 Million
Q1 2024

May 13, 2024

BUY
N/A
16,300 New
16,300 $136,000
Q1 2023

May 12, 2023

SELL
$7.32 - $10.85 $1.19 Million - $1.76 Million
-162,500 Reduced 88.85%
20,400 $203,000
Q4 2022

Feb 13, 2023

SELL
$7.84 - $11.68 $270,229 - $402,586
-34,468 Reduced 15.86%
182,900 $1.47 Million
Q3 2022

Nov 14, 2022

BUY
$10.73 - $20.07 $1.35 Million - $2.53 Million
126,068 Added 138.08%
217,368 $2.33 Million
Q2 2022

Aug 12, 2022

SELL
$6.76 - $14.18 $256,204 - $537,422
-37,900 Reduced 29.33%
91,300 $988,000
Q1 2022

May 13, 2022

BUY
$11.13 - $23.04 $754,280 - $1.56 Million
67,770 Added 110.32%
129,200 $1.67 Million
Q4 2021

Feb 11, 2022

BUY
$21.81 - $48.96 $500,103 - $1.12 Million
22,930 Added 59.56%
61,430 $1.36 Million
Q3 2021

Nov 12, 2021

SELL
$29.03 - $38.62 $2.04 Million - $2.72 Million
-70,400 Reduced 64.65%
38,500 $1.15 Million
Q2 2021

Aug 13, 2021

BUY
$32.29 - $39.68 $3.52 Million - $4.32 Million
108,900 New
108,900 $4.16 Million

Others Institutions Holding CMPS

About COMPASS Pathways plc


  • Ticker CMPS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 42,522,400
  • Market Cap $363M
  • Description
  • COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that has completed Phase IIb clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder. Th...
More about CMPS
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.